<DOC>
	<DOCNO>NCT02887820</DOCNO>
	<brief_summary>This pilot study seek evaluate feasibility safety use TEG algorithm addition traditional laboratory test guide transfusion coagulation management ECMO patient .</brief_summary>
	<brief_title>Evaluating Use Thromboelastography ( TEG ) Patient 's Requiring Extracorporeal Membrane Oxygenation ( ECMO )</brief_title>
	<detailed_description>All adult patient require ECMO consider trial , target enrollment 50 participant two-year period . For enrolled participant , TEG transfusion algorithm follow patient exhibit inadequate hemostasis operating room ( Flowchart 1 ) , second TEG algorithm follow ICU hemostasis normal heparin introduce ( Flowchart 2 ) . In addition determine compliance feasibility follow TEG algorithm , clinical outcome data include transfusion rate , type blood product transfuse , estimate blood loss thrombotic event collect every enrolled patient discontinue ECMO . Statistical analysis primary , secondary tertiary endpoint study determine likelihood explore future clinical trial involve TEG-driven coagulation transfusion management ECMO population .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Patient 's require ECMO placement Other child less 18 year age , one exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>ECMO</keyword>
	<keyword>TEG</keyword>
</DOC>